DUTASTERIDE / TAMSULOSIN (Combodart®)
Clinical Indication
Benign Prostatic Hyperplasia
Date of classification
June 2015
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.